Inscription à l’infolettre

Publications

Publications récentes

Voir les publications précédentes
  • 5 novembre 2018

    The Impact of Post-transcriptional Control: Better Living Through RNA Regulons.

    Culjkovic-Kraljacic B, Borden K
    Front Genet 2018-11-05 ;9:512

  • 1er novembre 2018

    Novel PDE10A-BRAF Fusion With Concomitant NF1 Mutation Identified in an Undifferentiated Sarcoma of Infancy With Sustained Response to Trametinib.

    Vairy S, Jouan L, Bilodeau M, Dormoy-Raclet V, Gendron P, Couture F, Léveillé F, Tihy F, Lemyre E, Bouron-Dal Soglio D, Jabado N, Kleinman CL, Marzouki M, Cellot S
    JCO Precis Oncol 2018-11-01 ;2:1-13

  • 1er novembre 2018

    Structural insights into binding specificity, efficacy and bias of a β2AR partial agonist.

    Masureel M, Zou Y, Picard LP, van der Westhuizen E, Mahoney JP, Rodrigues JPGLM, Mildorf TJ, Dror RO, Shaw DE, Bouvier M, Pardon E, Steyaert J, Sunahara RK, Weis WI, Zhang C, Kobilka BK
    Nat. Chem. Biol. 2018-11-01 ;14( 11 ):1059-1066

  • 26 octobre 2018

    Spatiotemporal regulation of the GPCR activity of BAI3 by C1qL4 and Stabilin-2 controls myoblast fusion.

    Hamoud N, Tran V, Aimi T, Kakegawa W, Lahaie S, Thibault MP, Pelletier A, Wong GW, Kim IS, Kania A, Yuzaki M, Bouvier M, Côté JF
    Nat Commun 2018-10-26 ;9( 1 ):4470

  • 23 octobre 2018

    Translating biased signaling in the ghrelin receptor system into differential in vivo functions.

    Mende F, Hundahl C, Plouffe B, Skov LJ, Sivertsen B, Madsen AN, Lückmann M, Diep TA, Offermanns S, Frimurer TM, Bouvier M, Holst B
    Proc. Natl. Acad. Sci. U.S.A. 2018-10-23 ;115( 43 ):E10255-E10264

  • 22 octobre 2018

    Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1.

    Daou S, Barbour H, Ahmed O, Masclef L, Baril C, Sen Nkwe N, Tchelougou D, Uriarte M, Bonneil E, Ceccarelli D, Mashtalir N, Tanji M, Masson JY, Thibault P, Sicheri F, Yang H, Carbone M, Therrien M, Affar EB
    Nat Commun 2018-10-22 ;9( 1 ):4385

  • 19 octobre 2018

    A simple approach for multi-targeted shRNA-mediated inducible knockdowns using Sleeping Beauty vectors.

    Fink S, Zugelder L, Roth B, Brandt E, Meloche S, Izsvák Z, Bargou RC, Stühmer T
    PLoS ONE 2018-10-19 ;13( 10 ):e0205585

  • 15 octobre 2018

    HIV-1 Employs Multiple Mechanisms To Resist Cas9/Single Guide RNA Targeting the Viral Primer Binding Site.

    Wang Z, Wang W, Cui YC, Pan Q, Zhu W, Gendron P, Guo F, Cen S, Witcher M, Liang C
    J Virol 2018-10-15 ;92( 20 ):

Voir plus de publications